StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $2.03 | $2.09 | +2.96% | 0.3M |
| 05-12 | $2.09 | $2.00 | -4.31% | 0.2M |
| 05-13 | $2.03 | $1.96 | -3.45% | 0.1M |
| 05-14 | $2.00 | $2.00 | +0.00% | 0.4M |
| 05-15 | $1.92 | $1.88 | -2.08% | 0.1M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
These are published opinions from external sell-side analysts — not Stonvex recommendations. Ratings may change without notice, may conflict with each other, and may be wrong. Not investment advice.
Consensus aggregated from publicly disclosed sell-side analyst ratings. Stonvex is not a registered investment advisor and does not endorse any of the ratings shown. Past analyst ratings do not predict future price movements.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $192.78K | $204.12K | $306.34K | $222.72K |
Operating Income | $-86.27M | $-269.74M | $-107.67M | $-5.03M |
Net Income | $-86.24M | $-282.50M | $-99.85M | $3.56M |
EPS (Diluted) | $-1.19 | $-11.16 | $-11.79 | $10.45 |
Total Assets | $181.00M | $269.08M | $443.96M | $17.09M |
Total Liabilities | $2.22M | $4.70M | $10.75M | $2.55M |
Cash & Equivalents | $12.32M | $10.38M | $10.52M | $8.32M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-15.15M | $-6.32M |
Shares Outstanding | 39.42M | 29.00M | 27.63M | 1.02M |
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's segment includes: Medical Device: This segment is responsible for executing and managing the Company's medical device sales and distribution business; and Digital Asset Treasury: This segment is responsible for executing and managing the Company's treasury platform.